Huanran Zhou Selected Research

Glucagon-Like Peptide 1 (GLP 1)

12/2019

Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huanran Zhou Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 12/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Disease Progression 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Non-alcoholic Fatty Liver Disease 12/2019
1	Alcoholic Fatty Liver 12/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2011
1	Lymphoid Leukemia 10/2009

Drug/Important Bio-Agent (IBA)

1	RNA (Ribonucleic Acid)IBA 01/2023
1	ruxolitinibIBA 01/2022
1	Cytochromes b5 (Cytochrome b5)IBA 01/2022
1	C-PeptideIBA 01/2022
1	CreatinineIBA 01/2022
1	Phospholipase C betaIBA 12/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021
1	Phospholipases (Phospholipase)IBA 12/2021
1	Long Noncoding RNAIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Liraglutide FDA Link 12/2019
1	LipidsIBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019
1	InflammasomesIBA 12/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	bis(2,2'- bipyridyl)(dipyrido(3,2- alpha- 2',3'- c)phenazine)ruthenium (II)IBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	Sulfhydryl Compounds (Thiols)IBA 10/2009

Therapy/Procedure

1	Immunotherapy 01/2023